Reply To: Traders Market Weekly: Inflation Obsession in Worsening Liquidity


Healthcare sector has several events worth tracking next week.

REGENXBIO’s (NASDAQ:RGNX) will hold a conference call on October 3 to provide a new, interim update from the ongoing Phase II AAVIATE trial of RGX-314.

On October 6, the FDA Vaccines and Related Biological Products Advisory Committee will take place and the FDA’s Pulmonary-Allergy Drugs Advisory Committee will meet to discuss the Veru’s (NASDAQ:VERU) request for Emergency Use Authorization of sabizabulin for hospitalized COVID-19 patients at high risk for ARDS. Shares of Veru have been volatile before off sabizabulin developments.